Global Obesity Drugs Market valued at $2.3 billion (2022) is poised for a High CAGR of 25% by 2027.

Some of the key factors driving the growth of the obesity drugs market include an increasing overweight and obese population, global adoption of sedentary lifestyles, high investments in R&D by market players to develop innovative pipelines, increased awareness of weight management programs, and rising disposable income in developing economies. Obesity and overweight are described as […]

Continue Reading

The digital PCR (dPCR) and real-time PCR (qPCR) market is projected to grow at a CAGR of 7% by 2028.

Some of the key factors driving the market for digital PCR (dPCR) and real-time PCR (qPCR) include the rising prevalence of chronic diseases, which is driving the need for precise diagnostic tools. Other factors include growing applications in oncology, infectious diseases, and genetic testing; technological advancements leading to improved efficiency and automation; and government initiatives […]

Continue Reading

Global Generative Artificial Intelligence (GenAI) in Healthcare Market is estimated to increase at a pace of 36-38% over the next five years.

Availability of vast amounts of healthcare data, including EHRs, medical imaging, and genomic data; growing applications in drug discovery; and the ability of generative AI to automate tasks, reduce errors, optimize treatment, and lower costs are some of the key factors driving the growth of the generative AI in healthcare market. Other factors driving the […]

Continue Reading

Global ESG Reporting Market is projected to grow at a healthy CAGR of ~15% by 2027

ESG Market is being driven by rising investor scrutiny, regulatory constraints, a growth in corporate data volumes, and the advent of AI for ESG data collecting, analytics, and reporting. Environmental, social, and governance (ESG) data assesses a company’s non-financial performance and sustainability policies. The three pillars of ESG include: · Environmental Data such as the quantity of greenhouse […]

Continue Reading

GCC Countries Digital Health Market is expected to develop steadily by 2027: Emerging growth opportunities and rising investments in Saudi Arabia and the UAE

Digital health primarily refers to the use and use of digital technology to manage various healthcare problems and improve the wellness sector. Telehealth, mHealth Apps, Connected Medical Devices & Services, Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Remote Patient Monitoring, Healthcare Analytics, Digital Therapeutics, and other categories are all part of the global digital […]

Continue Reading

The High Throughput Screening Market is poised to witness a growth rate of ~8.5% by 2029.

Growing investments in drug discovery research and development by the pharmaceutical and biotechnology industries, the need for cost-effective screening solutions, the growing emphasis on personalized medicine and precision therapeutics, and the growing demand for novel drug discovery and development are the main factors driving the market. High Throughput Screening (HTS) is the technique of testing […]

Continue Reading
Healthcare Management Service Organization (MSO) Market

The Healthcare Management Service Organization (MSO) Market on Track for Substantial Expansion by 2027

Some of the key factors driving the market include the growing trend of consolidating smaller practices to achieve economies of scale and improve operational efficiency, an aging population and chronic diseases, growing demand for specialty care, increased investments by private equity firms, and rising technology adoption. A Healthcare Management Service Organization (MSO) is a health-care company […]

Continue Reading

Decentralized Clinical Trials (DCTs) Market valued at US$ 8.8 billion in 2021 and is expected to grow at a CAGR of 10% to reach ~US$ 14.2 billion by 2026

Decentralized clinical trials (DCT) employ a method of conducting clinical trials where parts or all of the trial happen outside a traditional physical clinic or trial site. Telemedicine, local/mobile healthcare providers, and digital/mobile technology are used to perform clinical trial studies. The Global Decentralized Clinical Trials (DCTs) Market valued at US$ 8.8 billion (2021) is set to […]

Continue Reading

Global multi-omics market, which largely includes genomics, transcriptomics, proteomics, and metabonomics, is expected to increase at a pace of 16%.

The next phase of expansion is expected to be driven by expanding demand for customized treatment, technological improvements, a favorable financing environment, an increasing number of cancer and genetic illnesses, and an increase in R&D expenditure. To learn more about the research report, download a sample report. Omics has emerged as a new paradigm in molecular research. The suffix -omics refers to a branch of research in biological sciences. Many areas of research can be classed as omics, including genomes, transcriptomics, proteomics, and metabolomics. Genomics studies genes and […]

Continue Reading

Global Augmented Reality (AR) and Virtual Reality (VR) in the healthcare Market is predicted to expand at a rate of 30-35 percent.

The market is driven by technical improvements and increased digitalization, as well as government efforts, a large number of start-ups entering this field, a diverse range of applications, and expanding partnerships/M&As and financing levels. To learn more about the research report, download a sample report. AR technology enhances the actual world by adding data, whereas VR is a totally digital, computer-generated, 3D experiencing environment. While AR and VR technologies were first adopted solely by the gaming industry, other industries, including healthcare, are rapidly realizing their benefits and investigating […]

Continue Reading